1 − AR'()*+(, OR Source: Grant, R. L. (2014). Converting an odds ratio to a range of plausible relative risks for better communication of research findings. BMJ, 348(4), f7450.
30.7% in the TAVI group 50.7% in the standard therapy group NNT(12-months) = 5 • HR uses all data at each time point • Not robust to departures from proportionality
Treatment A B Treatment A B Treatment arm Panel 1 (HR = 3) Panel 2 (HR = 1.5) A 1 1 B 0.9 0.5 Median survival times (years) Spruance SL et al. Hazard ratio in clinical trials. AntimicrobAgents Chemother 2004;48:2787–92.